IDYA logo

IDEAYA Biosciences (IDYA) Cash From Investing

Annual CFI

-$502.56 M
-$344.10 M-217.16%

December 31, 2024

Summary

Performance

1-Year Change

-217.16%

3-Year Change

-621.38%

5-Year Change

-22288.04%

15-Year Change

-5529.65%

IDYA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.11%
IDYA annual cash flow from investing activities is higher than 6.11% of companies in Healthcare sector

High & Low

All-time High

$2.27 M
IDYA annual cash flow from investing activities is currently <-9900.00% below its historical high of $2.27 million

3-Year Low

-$502.56 M
IDYA annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
IDYA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
IDYA next annual earnings announcement has not yet been scheduled

OtherIDYAcash flowmetrics:

Annual CFF

$677.55 M
IDYA annual cash flow from financing activities is $677.55 million

Annual CFO

-$247.58 M
IDYA annual cash flow from operations is -$247.58 million

Annual FCF

-$251.44 M
IDYA annual free cash flow is -$251.44 million

Annual CAPEX

$3.86 M
IDYA annual capital expenditures is $3.86 million

Quarterly CFI

-$197.11 M
-$177.07 M-883.77%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+44.31%

3-Year Change

+44.31%

5-Year Change

+44.31%

IDYA Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.07%
IDYA quarterly cash flow from investing activities is higher than 5.07% of companies in Healthcare sector

High & Low

All-time High

$68.56 M
IDYA quarterly cash flow from investing activities is currently -387.51% below its historical high of $68.56 million

3-Year Low

-$353.97 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IDYA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
IDYA next earnings announcement is scheduled for May 7, 2025

OtherIDYAcash flowmetrics:

Quarterly CFF

$2.75 M
IDYA quarterly cash flow from financing activities is $2.75 million

Quarterly CFO

-$121.66 M
IDYA quarterly cash flow from operations is -$121.66 million

Quarterly FCF

-$122.76 M
IDYA quarterly free cash flow is -$122.76 million

Quarterly CAPEX

$1.10 M
IDYA quarterly capital expenditures is $1.10 million

TTM CFI

-$502.56 M
-$85.17 M-20.40%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+6.23%

3-Year Change

+6.23%

5-Year Change

+6.23%

IDYA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.27%
IDYA TTM cash flow from investing activities is higher than 6.27% of companies in Healthcare sector

High & Low

All-time High

$48.66 M
IDYA TTM cash flow from investing activities is currently -1132.88% below its historical high of $48.66 million

3-Year Low

-$535.95 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IDYA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
IDYA next earnings announcement is scheduled for May 7, 2025

OtherIDYAcash flowmetrics:

TTM CFF

$677.55 M
IDYA TTM cash flow from financing activities is $677.55 million

TTM CFO

-$247.58 M
IDYA TTM cash flow from operations is -$247.58 million

TTM FCF

-$251.44 M
IDYA TTM free cash flow is -$251.44 million

TTM CAPEX

$3.86 M
IDYA TTM capital expenditures is $3.86 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IDYA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-217.2%+44.3%+6.2%
3 y3 years-621.4%+44.3%+6.2%
5 y5 years-10000.0%+44.3%+6.2%

IDYA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1404.5%at low-387.5%+44.3%-6479.3%+6.2%
5 y5-year<-9999.0%at low-387.5%+44.3%-6479.3%+6.2%
alltimeall time<-9999.0%at low-387.5%+44.3%-1132.9%+6.2%

IDEAYA Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$502.56 M(+217.2%)
-$197.11 M(+883.8%)
-$502.56 M(+20.4%)
Sep 2024
-
-$20.04 M(-129.2%)
-$417.39 M(+20.6%)
Jun 2024
-
$68.56 M(-119.4%)
-$346.01 M(-35.4%)
Mar 2024
-
-$353.97 M(+216.2%)
-$535.95 M(+238.2%)
Dec 2023
-$158.46 M(+374.4%)
-$111.94 M(-318.0%)
-$158.46 M(+179.0%)
Sep 2023
-
$51.35 M(-142.3%)
-$56.79 M(-55.2%)
Jun 2023
-
-$121.38 M(-616.1%)
-$126.82 M(-1709.8%)
Mar 2023
-
$23.52 M(-328.9%)
$7.88 M(-123.6%)
Dec 2022
-$33.40 M(-52.1%)
-$10.28 M(-45.0%)
-$33.40 M(+41.9%)
Sep 2022
-
-$18.68 M(-240.3%)
-$23.54 M(-61.5%)
Jun 2022
-
$13.32 M(-175.0%)
-$61.16 M(-50.6%)
Mar 2022
-
-$17.76 M(+4200.5%)
-$123.86 M(+77.8%)
Dec 2021
-$69.67 M
-$413.00 K(-99.3%)
-$69.67 M(-5.6%)
Sep 2021
-
-$56.31 M(+14.0%)
-$73.81 M(-63.3%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$49.38 M(-235.5%)
-$201.08 M(+66.6%)
Mar 2021
-
$36.44 M(-900.1%)
-$120.71 M(-17.5%)
Dec 2020
-$146.24 M(-6556.6%)
-$4.55 M(-97.5%)
-$146.24 M(+6.1%)
Sep 2020
-
-$183.58 M(-692.4%)
-$137.80 M(-1977.4%)
Jun 2020
-
$30.99 M(+184.1%)
$7.34 M(-160.0%)
Mar 2020
-
$10.91 M(+180.6%)
-$12.24 M(-640.3%)
Dec 2019
$2.27 M(-103.6%)
$3.89 M(-110.1%)
$2.27 M(-54.3%)
Sep 2019
-
-$38.44 M(-436.9%)
$4.95 M(-89.8%)
Jun 2019
-
$11.41 M(-55.1%)
$48.66 M(+114.1%)
Mar 2019
-
$25.41 M(+286.4%)
$22.72 M(-136.0%)
Dec 2018
-$63.18 M(+607.7%)
$6.58 M(+25.0%)
-$63.18 M(-9.4%)
Sep 2018
-
$5.26 M(-136.2%)
-$69.75 M(-7.0%)
Jun 2018
-
-$14.52 M(-76.0%)
-$75.02 M(+24.0%)
Mar 2018
-
-$60.49 M
-$60.49 M
Dec 2017
-$8.93 M
-
-

FAQ

  • What is IDEAYA Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for IDEAYA Biosciences?
  • What is IDEAYA Biosciences annual CFI year-on-year change?
  • What is IDEAYA Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for IDEAYA Biosciences?
  • What is IDEAYA Biosciences quarterly CFI year-on-year change?
  • What is IDEAYA Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for IDEAYA Biosciences?
  • What is IDEAYA Biosciences TTM CFI year-on-year change?

What is IDEAYA Biosciences annual cash flow from investing activities?

The current annual CFI of IDYA is -$502.56 M

What is the all time high annual CFI for IDEAYA Biosciences?

IDEAYA Biosciences all-time high annual cash flow from investing activities is $2.27 M

What is IDEAYA Biosciences annual CFI year-on-year change?

Over the past year, IDYA annual cash flow from investing activities has changed by -$344.10 M (-217.16%)

What is IDEAYA Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of IDYA is -$197.11 M

What is the all time high quarterly CFI for IDEAYA Biosciences?

IDEAYA Biosciences all-time high quarterly cash flow from investing activities is $68.56 M

What is IDEAYA Biosciences quarterly CFI year-on-year change?

Over the past year, IDYA quarterly cash flow from investing activities has changed by +$156.86 M (+44.31%)

What is IDEAYA Biosciences TTM cash flow from investing activities?

The current TTM CFI of IDYA is -$502.56 M

What is the all time high TTM CFI for IDEAYA Biosciences?

IDEAYA Biosciences all-time high TTM cash flow from investing activities is $48.66 M

What is IDEAYA Biosciences TTM CFI year-on-year change?

Over the past year, IDYA TTM cash flow from investing activities has changed by +$33.39 M (+6.23%)